biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Tailwinds Research and Screen Door Manufac

<< Previous

Bullboard Posts

Next >>

Post by Boomskidon May 15, 2023 4:04pm

150 Views

Post# 35448936

Tailwinds Research and Screen Door Manufac

Daniel Carlson of Tailwinds Research and Screen Door Manufacturing is the most pedestrian stock tout who ever foisted himself into the public domain.

You can find Daniel and his Lyins Den here.

Invest with Tailpipe Research and kiss your assets goodbye.

jd

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale